Find your protocol by what you're researching.
Whether your endpoint is body-weight reduction, soft-tissue recovery, dermal collagen induction, or healthspan — start with the goal, not the molecule. Every category links to the same COAs, the same dosing math, the same overnight USA shipping.
Each one is a complete research lane.
Pick the goal you're researching. Each category page has its own essay, its own decision tree, its own filterable grid, and the stacks patients run alongside.
The GLP-1 lane.
Single-agonist semaglutide, dual GLP-1/GIP tirzepatide, and the new triple-agonist retatrutide. Same COA discipline across all three.
The repair lane.
BPC-157 systemic, TB-500 tissue rebuild, KPV anti-inflammatory. The original peptide research stack — soft tissue, gut, joint.
The collagen lane.
GHK-Cu copper peptide and the GLOW blend. Dermal collagen, hair follicle, melanocyte modulation — the cosmesis research stack.
The output lane.
Ipamorelin/CJC-1295 GH pulse and MOTS-c mitochondrial peptide. Pulsatile GH, body composition, exercise capacity research.
The visceral lane.
Larazotide tight-junction modulation and Tesamorelin hepatic visceral fat. The barrier-and-deep-fat research stack.
The healthspan lane.
Epitalon telomerase activator and NAD+ precursor. Sirtuins, mitochondrial biogenesis, telomere maintenance research.
